galantamine and Long Sleeper Syndrome

galantamine has been researched along with Long Sleeper Syndrome in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's8 (57.14)29.6817
2010's3 (21.43)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Hamada, M; Murata, T1
Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H1
Lewis, SJ; Szeto, JY1
Chankrachang, S; Nidhinandana, S; Phanthumchinda, K; Poungvarin, N; Praditsuwan, R; Senanarong, V; Tavichachart, N1
Ishida, T; Kamei, C1
Hirase, M; Ishida, T; Kamei, C; Takeda, Y1
Krasakov, IV; Litvinenko, IV; Tikhomirova, OV1
Gutterman, EM; Lilienfeld, S; Markowitz, JS; Papadopoulos, G1
Markowitz, JS; Papadopoulos, G; Sadik, K; Stahl, SM1
Herrmann, N; Lanctôt, KL; Thompson, S1
Borson, S; Kaufer, DI; Kershaw, P; Sadik, K1
Ancoli-Israel, S; Cooke, JR; Corey-Bloom, J; Fiorentino, L; Harrison, T; Liu, L; Loredo, JS; Marler, M1
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G1
Backhaus, J; Berger, M; Ebert, D; Faulmann, A; Gann, HJ; Hohagen, F; Hornyak, M; Kiemen, A; Klein, T; Riemann, D; Voderholzer, U1

Reviews

3 review(s) available for galantamine and Long Sleeper Syndrome

ArticleYear
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome

2016
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
    Expert opinion on drug safety, 2004, Volume: 3, Issue:5

    Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome

2004
Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
    CNS spectrums, 2005, Volume: 10, Issue:6

    Topics: Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cost of Illness; Depression; Employment; Galantamine; Humans; Sleep Wake Disorders

2005

Trials

4 trial(s) available for galantamine and Long Sleeper Syndrome

ArticleYear
Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine.
    Sleep, 2003, Aug-01, Volume: 26, Issue:5

    Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Galantamine; Humans; Male; Prevalence; Severity of Illness Index; Sleep Wake Disorders

2003
Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Drugs & aging, 2006, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polysomnography; Rivastigmine; Sleep Stages; Sleep Wake Disorders

2006
Cholinergic neurotransmission, REM sleep and depression.
    Journal of psychosomatic research, 1994, Volume: 38 Suppl 1

    Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine

1994
Sleep and the cholinergic rem sleep induction test in patients with primary alcoholism.
    Sleep research online : SRO, 1998, Volume: 1, Issue:2

    Topics: Adult; Alcoholism; Cholinesterase Inhibitors; Double-Blind Method; Female; Galantamine; Humans; Male; Polysomnography; Sleep Wake Disorders; Sleep, REM

1998

Other Studies

7 other study(ies) available for galantamine and Long Sleeper Syndrome

ArticleYear
Lemborexant add-on further improves the effect of galantamine on sleep-wake disorder in Alzheimer's disease.
    International journal of clinical pharmacology and therapeutics, 2022, Volume: 60, Issue:10

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Pyridines; Pyrimidines; Sleep; Sleep Wake Disorders

2022
Galantamine improves sleep quality in patients with dementia.
    Acta neurologica Belgica, 2015, Volume: 115, Issue:4

    Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome

2015
The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:9

    Topics: Aged; Alzheimer Disease; Case-Control Studies; Cholinesterase Inhibitors; Female; Galantamine; Health Status Indicators; Humans; Male; Risk Factors; Sleep; Sleep Wake Disorders; Thailand

2008
Characteristic effects of anti-dementia drugs on rat sleep patterns.
    Journal of pharmacological sciences, 2009, Volume: 109, Issue:3

    Topics: Animals; Dementia; Donepezil; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Memantine; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Sleep, REM

2009
[Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2009, Volume: 29, Issue:1

    Topics: Animals; Donepezil; Galantamine; Indans; Male; Nootropic Agents; Piperidines; Piracetam; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Wakefulness

2009
[Sleep disorders in patients with dementia in Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:9

    Topics: Aged; Dementia; Female; Galantamine; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Sleep, REM

2011
Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.
    Current medical research and opinion, 2004, Volume: 20, Issue:4

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dreams; Galantamine; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders

2004